Capecitabine with or without bevacizumab as maintenance therapy in metastatic colorectal cancer: a real-world retrospective study in Vietnamese patients

In this first real-world study from Vietnam, maintenance therapy with bevacizumab plus capecitabine significantly improved PFS compared to capecitabine alone, with acceptable safety. These findings support the use of biologic-based maintenance strategies in appropriate patients and provide valuable evidence for guiding mCRC treatment in resource-constrained settings.